Paper33036588
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
Dineen R and 14 others. BMC Endocr Disord, 2020. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy. Papers, record 33036588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33036588
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Insufficiency | Major topic |
| Bone Resorption | Major topic |
| Cortisone | Major topic |
| Glucocorticoids | Major topic |
| Hormone Replacement Therapy | Major topic |
| Hydrocortisone | Major topic |
| Adult | |
| Bone Density | |
| Cross-Over Studies | |
| Humans | |
| Male | |
| Prospective Studies |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/K015176/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29891135 | 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis. | J Autoimmun | 2018 | https://conductscience.org/library/papers/29891135 | PubMed |
| 2 | 1149255 | Relative competition of corticosterone, cortisol, cortisone, 11-dexycortisol and prednisolone with (1,2-3H)-cortisol in various protein-binding radioassay systems. | Clin Chim Acta | 1975 | https://conductscience.org/library/papers/1149255 | PubMed |
| 3 | 15355454 | Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. | Clin Endocrinol (Oxf) | 2004 | https://conductscience.org/library/papers/15355454 | PubMed |
| 4 | 8273983 | Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. | Ann Intern Med | 1994 | https://conductscience.org/library/papers/8273983 | PubMed |
| 5 | 1592888 | Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. | J Clin Endocrinol Metab | 1992 | https://conductscience.org/library/papers/1592888 | PubMed |
| 6 | 9156031 | Glucocorticoid replacement therapy: are patients over treated and does it matter? | Clin Endocrinol (Oxf) | 1997 | https://conductscience.org/library/papers/9156031 | PubMed |
| 7 | 1740481 | Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. | J Clin Endocrinol Metab | 1992 | https://conductscience.org/library/papers/1740481 | PubMed |
| 8 | 9267320 | Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol-cortisone shuttle. | Clin Chem | 1997 | https://conductscience.org/library/papers/9267320 | PubMed |
| 9 | 9213012 | Circadian variation in bone resorption is not related to serum cortisol. | Bone | 1997 | https://conductscience.org/library/papers/9213012 | PubMed |
| 10 | 9303434 | Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. | DNA Cell Biol | 1997 | https://conductscience.org/library/papers/9303434 | PubMed |
| 11 | 17566815 | Glucocorticoid-induced osteoporosis: pathophysiology and therapy. | Osteoporos Int | 2007 | https://conductscience.org/library/papers/17566815 | PubMed |
| 12 | 18478875 | Adrenal insufficiency. | Clin Med (Lond) | 2008 | https://conductscience.org/library/papers/18478875 | PubMed |
| 13 | 12915682 | 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. | J Clin Endocrinol Metab | 2003 | https://conductscience.org/library/papers/12915682 | PubMed |
| 14 | 10962348 | Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. | Bone | 2000 | https://conductscience.org/library/papers/10962348 | PubMed |
| 15 | 10970940 | [Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease]. | Ann Endocrinol (Paris) | 2000 | https://conductscience.org/library/papers/10970940 | PubMed |
| 16 | 3263379 | The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. | J Clin Endocrinol Metab | 1988 | https://conductscience.org/library/papers/3263379 | PubMed |
| 17 | 14641795 | Use of alpha-blockers and the risk of hip/femur fractures. | J Intern Med | 2003 | https://conductscience.org/library/papers/14641795 | PubMed |
| 18 | 8799333 | Osteoblast cells (MG-63 and HOS) have aromatase and 5 alpha-reductase activities. | Biochem Mol Biol Int | 1996 | https://conductscience.org/library/papers/8799333 | PubMed |
| 19 | 21917861 | Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. | J Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21917861 | PubMed |
| 20 | 16151676 | Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. | Calcif Tissue Int | 2005 | https://conductscience.org/library/papers/16151676 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40337422 | Diverse clinical manifestations and management strategies in autoimmune polyglandular syndrome: a review of cases. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40337422 | PubMed |
| 38595261 | [Vertebral fractures combined with prolonged activated partial prothrombin time: A case report]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38595261 | PubMed |
| 37277810 | Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/37277810 | PubMed |
| 37141281 | Ocimum tenuiflorum extract (HOLIXERTM): Possible effects on hypothalamic-pituitary-adrenal (HPA) axis in modulating stress. | PLoS One | 2023 | https://conductscience.org/library/papers/37141281 | PubMed |
| 34512556 | Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34512556 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33036588
GET https://conductscience.org/api/papers/v1/33036588/references?page=2